Brucellosis (Malta Fever) Summary

Networked: 1957 relevant articles (115 outcomes, 218 trials/studies) for this Disease

Key Drugs and Agents for Brucellosis

1. Rifampin (Rifampicin) : 22 outcomes 22 studies in 101 results : FDA 13 Generic
   
2. Doxycycline (Vibramycin) : 22 outcomes 20 studies in 95 results : FDA 23 Generic
   
3. Vaccines : 13 outcomes 17 studies in 130 results : IBA
   
4. Streptomycin (Streptomycin Sulfate) : 11 outcomes 12 studies in 96 results : FDA 7
   
5. Antigens : 10 outcomes 20 studies in 228 results : IBA
   
6. Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole) : 9 outcomes 4 studies in 32 results : FDA 6 Generic
   
7. Anti-Bacterial Agents (Antibiotics) : 8 outcomes 2 studies in 88 results : IBA
   
8. Gentamicins (Gentamicin) : 6 outcomes 4 studies in 21 results : FDA 63 Generic
   
9. Antibodies : 5 outcomes 13 studies in 245 results : IBA
   
10. Immunoglobulin G (IgG) : 4 outcomes 13 studies in 86 results : IBA
    

Diseases Related to Brucellosis

1. Infection
2. HIV Infections (HIV Infection)
3. Communicable Diseases (Infectious Diseases)
4. Chronic Hepatitis (Chronic Active Hepatitis)
5. Plague (Bubonic Plague)

Key Therapies for Brucellosis

1. Therapeutics : 2 outcomes 2 studies in 3 results
   
2. Induced Abortion (Induced Abortions) : 1 outcome 3 studies in 5 results
   
3. Drug Therapy (Chemotherapy) : 1 outcome 2 studies in 26 results
   
4. Microspheres (Microsphere) : 1 outcome in 3 results
   
5. Injections : 1 outcome in 3 results